Metaphore Biotechnologies
Unlocking the therapeutic potential of biomimicry
Unlocking the therapeutic potential of biomimicry
Metaphore Biotechnologies is a pioneering biotechnology startup with a focus on harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics. The company's MIMiC™ platform is a computationally driven bioplatform that designs new therapeutics with optimized function, specificity, and selectivity. Founded in 2021 within Flagship Labs, a unit of Flagship Pioneering, Metaphore is committed to making previously intractable drug targets accessible and unlocking breakthroughs that outperform today's drugs, ultimately maximizing patient impact. The latest investment round of $50.00M, led by Flagship Pioneering on 16 May 2023, further solidifies Metaphore's position as a promising player in the biotechnology industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Funding Round | $50.00M | 1 |
|
16 May 2023 |
No recent news or press coverage available for Metaphore Biotechnologies.
We care about your data, and we'd love to use cookies make your experience better.